scispace - formally typeset
K

Kanneboyina Nagaraju

Researcher at Binghamton University

Publications -  189
Citations -  9970

Kanneboyina Nagaraju is an academic researcher from Binghamton University. The author has contributed to research in topics: Duchenne muscular dystrophy & Skeletal muscle. The author has an hindex of 52, co-authored 181 publications receiving 8793 citations. Previous affiliations of Kanneboyina Nagaraju include Children's National Medical Center & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy

TL;DR: It is proposed that in cancer-associated myositis, an autoimmune response directed against cancer cross-reacts with regenerating muscle cells, enabling a feed-forward loop of tissue damage and antigen selection and Regulating pathways of antigen expression may provide unrecognized therapeutic opportunities in autoimmune diseases.
Journal ArticleDOI

Activation of the endoplasmic reticulum stress response in autoimmune myositis: Potential role in muscle fiber damage and dysfunction

TL;DR: Investigating the pathways of endoplasmic reticulum stress response, the unfolded protein response, and the ER overload response in muscle tissue of human myositis patients and in the mouse model indicates that the ER stress response may be a major nonimmune mechanism responsible for skeletal muscle damage and dysfunction in autoimmune myositIS.
Journal ArticleDOI

Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy

TL;DR: A wide range of techniques used to measure parameters of muscle pathology in mdx mice are described and some basic techniques that might comprise standardised approaches for evaluation are identified.
Journal ArticleDOI

Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies.

TL;DR: It is suggested that an autoimmune disease may unfold in a highly specific pattern as the consequence of an apparently nonspecific event-the sustained up-regulation of MHC class I in a tissue-and that the specificity of the autoantibodies derives not from the specificityOf the stimulus, but from the context, location, and probably the duration of the stimulus.